reported that ALDH1A3 and ALDH1L1 are potentially major contributors to ALDH1 activities in GC, and high mRNA expressions of ALDH1A3 and ALDH1L1 predict poorer OS in GC patients.114. The gene discussed is ALDH1L1; the disease is gastric cancer.